Johnson & Johnson Stock

Johnson & Johnson EBIT 2024

Johnson & Johnson EBIT

27.24 B USD

Ticker

JNJ

ISIN

US4781601046

WKN

853260

In 2024, Johnson & Johnson's EBIT was 27.24 B USD, a 12.31% increase from the 24.25 B USD EBIT recorded in the previous year.

The Johnson & Johnson EBIT history

YEAREBIT (undefined USD)
2029e36.81
2028e34.44
2027e32.25
2026e31.11
2025e29.55
2024e27.24
202324.25
202223.29
202120.63
202020.52
201918.6
201820.22
201719.39
201620.93
201520.47
201421.21
201317.07
201217.14
201113.41
201017.18
200917.19
200817.18
200714.68
200614.38
200513.05
200412.34

Johnson & Johnson Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Johnson & Johnson, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Johnson & Johnson from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Johnson & Johnson’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Johnson & Johnson. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Johnson & Johnson’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Johnson & Johnson’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Johnson & Johnson’s growth potential.

Johnson & Johnson Revenue, EBIT and net profit per share

DateJohnson & Johnson RevenueJohnson & Johnson EBITJohnson & Johnson Net Income
2029e106.72 B undefined36.81 B undefined31.65 B undefined
2028e102.61 B undefined34.44 B undefined29.51 B undefined
2027e98.42 B undefined32.25 B undefined27.83 B undefined
2026e95.82 B undefined31.11 B undefined27.2 B undefined
2025e92.26 B undefined29.55 B undefined25.74 B undefined
2024e89.68 B undefined27.24 B undefined24.2 B undefined
202385.16 B undefined24.25 B undefined35.15 B undefined
202279.99 B undefined23.29 B undefined17.94 B undefined
202178.74 B undefined20.63 B undefined20.88 B undefined
202082.58 B undefined20.52 B undefined14.71 B undefined
201982.06 B undefined18.6 B undefined15.12 B undefined
201881.58 B undefined20.22 B undefined15.3 B undefined
201776.45 B undefined19.39 B undefined1.3 B undefined
201671.89 B undefined20.93 B undefined16.54 B undefined
201570.07 B undefined20.47 B undefined15.41 B undefined
201474.33 B undefined21.21 B undefined16.32 B undefined
201371.31 B undefined17.07 B undefined13.83 B undefined
201267.22 B undefined17.14 B undefined10.85 B undefined
201165.03 B undefined13.41 B undefined9.67 B undefined
201061.59 B undefined17.18 B undefined13.33 B undefined
200961.9 B undefined17.19 B undefined12.27 B undefined
200863.75 B undefined17.18 B undefined12.95 B undefined
200761.1 B undefined14.68 B undefined10.58 B undefined
200653.32 B undefined14.38 B undefined11.05 B undefined
200550.51 B undefined13.05 B undefined10.06 B undefined
200447.35 B undefined12.34 B undefined8.18 B undefined

Johnson & Johnson stock margins

The Johnson & Johnson margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Johnson & Johnson. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Johnson & Johnson.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Johnson & Johnson's sales revenue. A higher gross margin percentage indicates that the Johnson & Johnson retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Johnson & Johnson's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Johnson & Johnson's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Johnson & Johnson's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Johnson & Johnson. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Johnson & Johnson's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Johnson & Johnson Margin History

Johnson & Johnson Gross marginJohnson & Johnson Profit marginJohnson & Johnson EBIT marginJohnson & Johnson Profit margin
2029e69.18 %34.5 %29.65 %
2028e69.18 %33.57 %28.76 %
2027e69.18 %32.77 %28.27 %
2026e69.18 %32.47 %28.39 %
2025e69.18 %32.02 %27.9 %
2024e69.18 %30.37 %26.98 %
202369.18 %28.48 %41.28 %
202269.25 %29.11 %22.43 %
202170.28 %26.2 %26.52 %
202065.7 %24.84 %17.82 %
201966.54 %22.67 %18.42 %
201866.92 %24.78 %18.75 %
201766.84 %25.36 %1.7 %
201669.9 %29.11 %23.01 %
201569.38 %29.21 %21.99 %
201469.4 %28.54 %21.96 %
201369.63 %23.94 %19.4 %
201267.78 %25.5 %16.14 %
201168.69 %20.62 %14.87 %
201069.49 %27.89 %21.65 %
200970.2 %27.77 %19.82 %
200870.96 %26.96 %20.31 %
200770.95 %24.03 %17.31 %
200671.76 %26.97 %20.73 %
200572.27 %25.82 %19.92 %
200471.54 %26.06 %17.28 %

Johnson & Johnson Aktienanalyse

What does Johnson & Johnson do?

Johnson & Johnson is an American company that was founded in 1886 by the brothers Robert, James, and Edward Johnson. The company is headquartered in New Brunswick, New Jersey, USA and is now an internationally operating company with more than 130,000 employees worldwide. The history of Johnson & Johnson began with the production of medical bandages. In 1887, the first self-adhesive wound plaster was invented and patented. In the following years, the product range was significantly expanded and now includes a wide range of health products. This includes pharmaceuticals, medical devices, hygiene products, personal care products, and baby products. The business model of Johnson & Johnson is to improve the lives of people worldwide. The company places great importance on innovation, quality, and sustainability. With its long-standing experience and expertise in the healthcare industry, Johnson & Johnson is able to understand the needs of customers and offer products tailored to their specific needs. Johnson & Johnson is now active in three main business areas: Consumer Health, Medical Devices and Diagnostics, and Pharmaceuticals. Within these business areas, there are a variety of brands and products that are among the most well-known in the world. The Consumer Health division of Johnson & Johnson is focused on the production of health and personal care products for consumers. Some well-known brands in this area include Listerine, Johnson's Baby, Neutrogena, and Nicorette. The company offers a wide range of products, from cold and allergy medications to skincare products and toothpastes. Medical Devices and Diagnostics is another major business area of Johnson & Johnson. The company is a leading provider of medical devices and diagnostic products worldwide. Products in this area include surgical systems, implantable devices, diagnostic tests, and imaging devices. Well-known brands in this area include Ethicon, Depuy Synthes, and Cordis. Pharmaceuticals is the third major business area of Johnson & Johnson. The company develops and produces innovative pharmaceuticals for the treatment of diseases such as cancer, diabetes, heart disease, and neurological disorders. Some well-known brands in this area include Remicade, Invega, and Zytiga. Johnson & Johnson is also known for its commitment to sustainability and corporate social responsibility. The company is committed to having a positive impact on the environment and the communities in which it operates. For example, Johnson & Johnson aims to reduce its CO2 emissions by 60% by 2030. Overall, Johnson & Johnson is a leading healthcare company focused on providing innovative and high-quality products that improve the lives of people worldwide. With a wide range of brands and products in various business areas, the company is well positioned to continue to be successful in the future. Johnson & Johnson ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Johnson & Johnson's EBIT

Johnson & Johnson's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Johnson & Johnson's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Johnson & Johnson's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Johnson & Johnson’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Johnson & Johnson stock

How much did Johnson & Johnson achieve in EBIT for the current year?

In the current year, Johnson & Johnson has achieved an EBIT of 27.24 B USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Johnson & Johnson.

How has the EBIT of Johnson & Johnson developed in recent years?

The EBIT of Johnson & Johnson has increased by 12.313% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Johnson & Johnson?

The EBIT of Johnson & Johnson is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Johnson & Johnson pay?

Over the past 12 months, Johnson & Johnson paid a dividend of 4.7 USD . This corresponds to a dividend yield of about 3.24 %. For the coming 12 months, Johnson & Johnson is expected to pay a dividend of 5.1 USD.

What is the dividend yield of Johnson & Johnson?

The current dividend yield of Johnson & Johnson is 3.24 %.

When does Johnson & Johnson pay dividends?

Johnson & Johnson pays a quarterly dividend. This is distributed in the months of March, June, September, December.

How secure is the dividend of Johnson & Johnson?

Johnson & Johnson paid dividends every year for the past 63 years.

What is the dividend of Johnson & Johnson?

For the upcoming 12 months, dividends amounting to 5.1 USD are expected. This corresponds to a dividend yield of 3.51 %.

In which sector is Johnson & Johnson located?

Johnson & Johnson is assigned to the 'Health' sector.

Wann musste ich die Aktien von Johnson & Johnson kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Johnson & Johnson from 12/10/2024 amounting to 1.24 USD, you needed to have the stock in your portfolio before the ex-date on 11/26/2024.

When did Johnson & Johnson pay the last dividend?

The last dividend was paid out on 12/10/2024.

What was the dividend of Johnson & Johnson in the year 2023?

In the year 2023, Johnson & Johnson distributed 4.45 USD as dividends.

In which currency does Johnson & Johnson pay out the dividend?

The dividends of Johnson & Johnson are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Johnson & Johnson stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank

Andere Kennzahlen von Johnson & Johnson

Our stock analysis for Johnson & Johnson Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Johnson & Johnson Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.